How pharma could feel the pain of a recession

At its core, the pharma industry is mostly safe from a market downturn, according to Arda Ural, EY-Parthenon Americas life sciences sector leader.

“Underlying fundamentals for the pharmaceutical industry make it relatively less exposed to a recession given the intrinsic nature of its business [such as] long product life cycles, patent protection and the strong cash flow position of the industry,” Ural said.